MELD Calculator

Model for End-Stage Liver Disease - Assess transplant priority and 90-day mortality risk

Calculate MELD Score

Formula Selection

The MELD-Na formula is the current standard used by transplant centers worldwide

Laboratory Values

Normal: 0.6-1.3 mg/dL (53-115 μmol/L). Minimum value used: 1.0 mg/dL

Normal: 0.3-1.2 mg/dL (5-21 μmol/L). Minimum value used: 1.0 mg/dL

Normal: 1.0-1.5. Minimum value used: 1.0

Normal: 135-145 mEq/L. Capped between 125-137 mEq/L for calculation

Dialysis Status

If checked, creatinine will be automatically set to 4.0 mg/dL for calculation

MELD Score Results

19
MELD-Na Score
Range: 1-40
Moderate Risk
Low-moderate transplant priority
6%
90-day mortality

Clinical Interpretation

Transplant Priority: Consider transplant evaluation if progressive

90-day Mortality Risk: 6% based on historical data

Values Used in Calculation

Creatinine:
1.00 mg/dL
Bilirubin:
1.00 mg/dL
INR:
1.00
Sodium:
125 mEq/L

Values are automatically adjusted to minimum thresholds required by MELD formula

Formula Used

MELD = 10 × [(0.957 × ln(1.00)) + (0.378 × ln(1.00)) + (1.12 × ln(1.00))] + 6.43 = 6

MELD-Na = 6 + 1.32 × (137 - 125) - 0.033 × 6 × (137 - 125)

MELD-Na Score = 19

⚠️ Critical Medical Information

The MELD score is used for liver transplant prioritization and should only be interpreted by qualified healthcare professionals. This calculator is not suitable for children under 12 years old.

Important: MELD scores are used alongside clinical judgment, blood type compatibility, geographic location, and other factors in transplant allocation decisions.

Example Calculation

Patient with End-Stage Liver Disease

Creatinine: 2.1 mg/dL

Bilirubin: 4.2 mg/dL

INR: 2.8

Sodium: 132 mEq/L

Dialysis: No

Calculation

Original MELD: 10 × [(0.957×ln(2.1)) + (0.378×ln(4.2)) + (1.12×ln(2.8))] + 6.43 = 25

MELD-Na: 25 + 1.32×(137-132) - 0.033×25×(137-132) = 27

Interpretation: High risk - 19.6% 90-day mortality, should be evaluated for transplant

MELD Score Ranges

40: Critical (71.3%)

Immediate transplant needed

30-39: Very High (52.6%)

Urgent transplant priority

20-29: High (19.6%)

Moderate transplant priority

10-19: Moderate (6.0%)

Low-moderate priority

≤9: Low (1.9%)

Continue monitoring

Required Laboratory Tests

  • Serum Creatinine: Kidney function indicator
  • Total Bilirubin: Liver function marker
  • INR: Blood clotting assessment
  • Serum Sodium: Electrolyte balance (MELD-Na only)

Normal Laboratory Values

Creatinine:0.6-1.3 mg/dL
Bilirubin:0.3-1.2 mg/dL
INR:1.0-1.5
Sodium:135-145 mEq/L
Age limit:≥12 years

Understanding the MELD Score

What is MELD?

The Model for End-Stage Liver Disease (MELD) is a scoring system used to prioritize patients for liver transplantation. It predicts 90-day mortality and helps ensure the sickest patients receive transplants first.

Clinical Applications

  • Liver transplant prioritization
  • 90-day mortality prediction
  • Treatment planning and prognosis
  • Resource allocation decisions

MELD vs MELD-Na

Original MELD (Pre-2016):

10 × [(0.957 × ln(creatinine)) + (0.378 × ln(bilirubin)) + (1.12 × ln(INR))] + 6.43

MELD-Na (2016-Current):

MELD + 1.32 × (137 - sodium) - 0.033 × MELD × (137 - sodium)

The MELD-Na formula includes serum sodium, which improves prediction accuracy for patients with low sodium levels (hyponatremia).

End-Stage Liver Disease

End-stage liver disease represents the final stage of chronic liver disease where the liver can no longer function adequately to sustain life without transplantation.

Common Causes

  • • Hepatitis B and C infection
  • • Alcoholic liver disease
  • • Non-alcoholic fatty liver disease (NAFLD)
  • • Primary biliary cholangitis
  • • Autoimmune hepatitis
  • • Hemochromatosis

Clinical Features

  • • Jaundice (elevated bilirubin)
  • • Ascites (fluid retention)
  • • Hepatic encephalopathy
  • • Coagulopathy (bleeding tendency)
  • • Portal hypertension
  • • Renal dysfunction

Transplant Allocation

MELD scores are used in conjunction with other factors for transplant allocation:

Medical Factors

  • • MELD score
  • • Blood type compatibility
  • • Organ size match
  • • Time on waiting list
  • • Geographic location

Special Situations

  • • Hepatocellular carcinoma
  • • Metabolic disorders
  • • Fulminant hepatic failure
  • • Status 1A patients
  • • Living donor availability

Contraindications

  • • Active alcohol/drug use
  • • Severe cardiac disease
  • • Advanced malignancy
  • • Uncontrolled infection
  • • Psychiatric instability